课题基金 / 基金详情

基于Akt1/Bad信号通路探索独一味总黄酮治疗“真布病”的作用机制及药效物质基础

批准号:
82104528
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
蒋运斌
依托单位:
学科分类:
民族药学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
蒋运斌

项目摘要

结项摘要

相似基金

相关文献

中文摘要
本项目针对抗“真布病”(相当于类风湿关节炎RA)药物药效物质基础及作用机制不明的难题,基于藏医药理论及临床实践经验,选择对“真布病”确有疗效的藏药独一味为研究对象。申请人前期基于网络药理学的研究表明,总黄酮是独一味抗RA的主要药效物质基础,抑制Akt1/Bad信号通路而诱导成纤维样滑膜细胞(FLS)凋亡可能是总黄酮抗RA的关键作用机制。然而该机制是否为独一味总黄酮抗RA的主要作用机制,其药效物质基础是什么,尚需进一步研究。据此提出假说:抑制Akt1/Bad信号通路而诱导FLS凋亡是独一味总黄酮抗“真布病”的主要作用机制,其药效物质基础由多个成分构成。项目将基于佐剂性关节炎模型大鼠、FLS,采用分子生物学、血清药理学、血清药物化学、虚拟筛选、等温滴定量热法等技术,从整体、细胞、分子水平阐明假说的科学内涵。为提供质量稳定可控、作用机制明确的独一味总黄酮用于“真布病”的防治奠定基础。
英文摘要
To solve the problem of unknown pharmacodynamic material basis and mechanism of drugs against “Zhenbu Disease” equivalent to rheumatoid arthritis (RA), this project selected the Tibetan medicine Lamiophlomis rotata (LR), which shows a real curative effect on “Zhenbu Disease”, as the research object based on Tibetan medicine theory and clinical practice experience. The applicant’s preliminary research based on network pharmacology showed that total flavonoids were the main pharmacodynamic material basis of LR against RA, and the key mechanism of total flavonoids against RA may be to induce apoptosis of fibroblast-like synoviocyte (FLS) by inactivating Akt1/Bad signaling pathway. However, further research needs to be carried out to clarify whether this mechanism is the main mechanism of LR total flavonoids against RA, and what is its pharmacodynamic material basis. Based on the above research foundation, a hypothesis was proposed that “Apoptosis of FLS mediated by inactivation of Akt1/Bad signaling pathway is the main mechanism of LR total flavonoids against ‘Zhenbu Disease’. And its pharmacodynamic material basis consists of multiple ingredients.” In the project, adjuvant-induced arthritis model rats and FLS were used to clarify the scientific connotation of the hypothesis from the overall, cellular and molecular levels based on multiple research methods, such as molecular biology, serum pharmacology, serum pharmacochemistry, virtual screening, and isothermal titration calorimetry. This project can lay the foundation for providing LR total flavonoids with stable and controllable quality and clear mechanism of action for the prevention and treatment of “Zhenbu Disease”.
独一味系藏族习用药材,为唇形科植物独一味Lamiophlomis rotata (Benth.) Kudo的干燥地上部分。在藏医药理论指导下独一味可用于“真布病”(相当于类风湿关节炎RA)的治疗,临床研究也确认了这一观点,但其药效物质及作用机制尚未阐明。项目执行人前期研究发现总黄酮是独一味抗RA的主要药效物质基础,抑制Akt1/Bad信号通路诱导成纤维样滑膜细胞(FLS)凋亡可能是独一味总黄酮(TFLR)抗RA的作用机制。故本项目首先基于胶原诱导性关节炎大鼠模型,以足肿胀、关节炎评分、脾指数、胸腺指数、血清炎症因子、踝关节组织病理学、膝关节滑膜组织病理学、滑膜组织中Akt1/Bad信号通路相关凋亡蛋白为指标,从整体水平剖析TFLR抗RA的作用及相关机制;然后通过网络药理学、谱效关系、入血成分分析、成分敲除实验从整体、细胞、分子水平上探究TFLR抗RA的关键药效物质基础;最后从Akt1/Bad信号通路介导FLS凋亡的角度,在细胞和分子水平上进一步探究和验证了TFLR及其关键药效成分抗RA的机制。体内实验结果显示,TFLR具有较好的抗RA作用,其作用机制与抑制Akt1/Bad信号通路诱导滑膜细胞凋亡有关。网络药理学、谱效关系、入血成分分析、成分敲除实验的整合结果显示,木犀草苷是TFLR抗RA的关键药效成分,而体内实际起作用的是木犀草素。体外实验结果显示,TFLR及木犀草素诱导SW982细胞凋亡的作用与抑制Akt1/Bad信号通路有关;而通路的抑制可能与靶向抑制Akt磷酸化有关。总体而言,本项目从Akt1/Bad信号通路介导的FLS凋亡角度揭示了TFLR抗RA的作用机制,同时阐明了其抗RA的药效物质基础。为提供质量稳定可控、作用机制明确的TFLR用于“真布病”的防治奠定基础。
国内基金
海外基金